331 related articles for article (PubMed ID: 10484511)
1. GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans.
Näslund E; Bogefors J; Skogar S; Grybäck P; Jacobsson H; Holst JJ; Hellström PM
Am J Physiol; 1999 Sep; 277(3):R910-6. PubMed ID: 10484511
[TBL] [Abstract][Full Text] [Related]
2. Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.
Meier JJ; Kemmeries G; Holst JJ; Nauck MA
Diabetes; 2005 Jul; 54(7):2212-8. PubMed ID: 15983224
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.
Nauck MA; Niedereichholz U; Ettler R; Holst JJ; Orskov C; Ritzel R; Schmiegel WH
Am J Physiol; 1997 Nov; 273(5):E981-8. PubMed ID: 9374685
[TBL] [Abstract][Full Text] [Related]
4. Involvement of endogenous glucagon-like peptide-1 in regulation of gastric motility and pancreatic endocrine secretion.
Witte AB; Grybäck P; Jacobsson H; Näslund E; Hellström PM; Holst JJ; Hilsted L; Schmidt PT
Scand J Gastroenterol; 2011 Apr; 46(4):428-35. PubMed ID: 21114428
[TBL] [Abstract][Full Text] [Related]
5. GLP-1 inhibits gastric emptying of water but does not influence plasma.
Näslund E; Bogefors J; Grybäck P; Bjellerup P; Jacobsson H; Holst JJ; Hellström PM
Scand J Gastroenterol; 2001 Feb; 36(2):156-62. PubMed ID: 11252407
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men.
Näslund E; Gutniak M; Skogar S; Rössner S; Hellström PM
Am J Clin Nutr; 1998 Sep; 68(3):525-30. PubMed ID: 9734726
[TBL] [Abstract][Full Text] [Related]
7. Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.
Willms B; Werner J; Holst JJ; Orskov C; Creutzfeldt W; Nauck MA
J Clin Endocrinol Metab; 1996 Jan; 81(1):327-32. PubMed ID: 8550773
[TBL] [Abstract][Full Text] [Related]
8. The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity.
Flint A; Raben A; Ersbøll AK; Holst JJ; Astrup A
Int J Obes Relat Metab Disord; 2001 Jun; 25(6):781-92. PubMed ID: 11439290
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release.
Enç FY; Imeryüz N; Akin L; Turoğlu T; Dede F; Haklar G; Tekeşin N; Bekiroğlu N; Yeğen BC; Rehfeld JF; Holst JJ; Ulusoy NB
Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G752-63. PubMed ID: 11518688
[TBL] [Abstract][Full Text] [Related]
10. Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility.
MacIntosh CG; Andrews JM; Jones KL; Wishart JM; Morris HA; Jansen JB; Morley JE; Horowitz M; Chapman IM
Am J Clin Nutr; 1999 May; 69(5):999-1006. PubMed ID: 10232642
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.
Gutniak MK; Juntti-Berggren L; Hellström PM; Guenifi A; Holst JJ; Efendic S
Diabetes Care; 1996 Aug; 19(8):857-63. PubMed ID: 8842604
[TBL] [Abstract][Full Text] [Related]
12. No effect of glucagon-like peptide-1 on short-term satiety and energy intake in man.
Long SJ; Sutton JA; Amaee WB; Giouvanoudi A; Spyrou NM; Rogers PJ; Morgan LM
Br J Nutr; 1999 Apr; 81(4):273-9. PubMed ID: 10999014
[TBL] [Abstract][Full Text] [Related]
13. Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.
Näslund E; Barkeling B; King N; Gutniak M; Blundell JE; Holst JJ; Rössner S; Hellström PM
Int J Obes Relat Metab Disord; 1999 Mar; 23(3):304-11. PubMed ID: 10193877
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1.
Nagell CF; Wettergren A; Pedersen JF; Mortensen D; Holst JJ
Scand J Gastroenterol; 2004 Apr; 39(4):353-8. PubMed ID: 15125467
[TBL] [Abstract][Full Text] [Related]
15. Ghrelin attenuates the inhibitory effects of glucagon-like peptide-1 and peptide YY(3-36) on food intake and gastric emptying in rats.
Chelikani PK; Haver AC; Reidelberger RD
Diabetes; 2006 Nov; 55(11):3038-46. PubMed ID: 17065340
[TBL] [Abstract][Full Text] [Related]
16. Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats.
Chelikani PK; Haver AC; Reidelberger RD
Am J Physiol Regul Integr Comp Physiol; 2005 Jun; 288(6):R1695-706. PubMed ID: 15718384
[TBL] [Abstract][Full Text] [Related]
17. Effect of glucagon on carbohydrate-mediated secretion of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-36 amide) (GLP-1).
Ranganath L; Schaper F; Gama R; Morgan L; Wright J; Teale D; Marks V
Diabetes Metab Res Rev; 1999; 15(6):390-4. PubMed ID: 10634963
[TBL] [Abstract][Full Text] [Related]
18. The glucagon-like peptide-1 metabolite GLP-1-(9-36) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans.
Meier JJ; Gethmann A; Nauck MA; Götze O; Schmitz F; Deacon CF; Gallwitz B; Schmidt WE; Holst JJ
Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1118-23. PubMed ID: 16403774
[TBL] [Abstract][Full Text] [Related]
19. Intravenous ghrelin accelerates postoperative gastric emptying and time to first bowel movement in humans.
Falkén Y; Webb DL; Abraham-Nordling M; Kressner U; Hellström PM; Näslund E
Neurogastroenterol Motil; 2013 Jun; 25(6):474-80. PubMed ID: 23527561
[TBL] [Abstract][Full Text] [Related]
20. Effects of GLP-1 on gastric emptying, antropyloric motility, and transpyloric flow in response to a nonnutrient liquid.
Anvari M; Paterson CA; Daniel EE; McDonald TJ
Dig Dis Sci; 1998 Jun; 43(6):1133-40. PubMed ID: 9635598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
